FDA Urged To Improve “Predictability” For Orphan Drugs By Social Security Head Astrue
This article was originally published in The Pink Sheet Daily
Executive Summary
Commissioner Hamburg urged to set regular briefings on orphan drug development. Policy at the top doesn’t always translate into the “trenches,” former TKT CEO says.